Literature DB >> 14755036

Vaginal yeast colonisation, prevalence of vaginitis, and associated local immunity in adolescents.

M M Barousse1, B J Van Der Pol, D Fortenberry, D Orr, P L Fidel.   

Abstract

OBJECTIVES: To evaluate point prevalence vaginal yeast colonisation and symptomatic vaginitis in middle adolescents and to identify relation of these yeast conditions with reproductive hormones, sexual activity, sexual behaviours, and associated local immunity.
METHODS: Middle adolescent females (n = 153) were evaluated for sexually transmitted infections (STIs), asymptomatic yeast colonisation, and symptomatic vulvovaginal candidiasis (VVC) by standard criteria. Also evaluated were local parameters, including vaginal associated cytokines, chemokines, and antibodies, vaginal epithelial cell antifungal activity, and Candida specific peripheral blood lymphocyte responses. Correlations between yeast colonisation/vaginitis and local immunomodulators, reproductive hormones, douching, sexual activity, condom use, and STIs were identified.
RESULTS: Rates of point prevalence asymptomatic yeast colonisation (22%) were similar to adults and similarly dominated by Candida albicans, but with uncharacteristically high vaginal yeast burden. In contrast with the high rate of STIs (18%), incidence of symptomatic VVC was low (<2%). Immunological properties included high rates of Candida specific systemic immune sensitisation, a Th2 type vaginal cytokine profile, total and Candida specific vaginal antibodies dominated by IgA, and moderate vaginal epithelial cell anti-Candida activity. Endogenous reproductive hormones were in low concentration. Sexual activity positively correlated with vaginal yeast colonisation, whereas vaginal cytokines (Th1, Th2, proinflammatory), chemokines, antibodies, contraception, douching, or condom use did not.
CONCLUSION: Asymptomatic vaginal yeast colonisation in adolescents is distinct in some ways with adults, and positively correlates with sexual activity, but not with local immunomodulators or sexual behaviours. Despite several factors predictive for VVC, symptomatic VVC was low compared to STIs.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14755036      PMCID: PMC1758371          DOI: 10.1136/sti.2002.003855

Source DB:  PubMed          Journal:  Sex Transm Infect        ISSN: 1368-4973            Impact factor:   3.519


  26 in total

1.  Evaluation of the bacterial vaginal flora of 20 postmenopausal women by direct (Nugent score) and molecular (polymerase chain reaction and denaturing gradient gel electrophoresis) techniques.

Authors:  Jeremy P Burton; Gregor Reid
Journal:  J Infect Dis       Date:  2002-11-22       Impact factor: 5.226

2.  Local Th1/Th2 cytokine production during experimental vaginal candidiasis: potential importance of transforming growth factor-beta.

Authors:  B N Taylor; M Saavedra; P L Fidel
Journal:  Med Mycol       Date:  2000-12       Impact factor: 4.076

3.  Candida vaginitis.

Authors:  R Hurley; J De Louvois
Journal:  Postgrad Med J       Date:  1979-09       Impact factor: 2.401

4.  Protection against candidiasis by an immunoglobulin G3 (IgG3) monoclonal antibody specific for the same mannotriose as an IgM protective antibody.

Authors:  Y Han; M H Riesselman; J E Cutler
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

5.  Multicenter evaluation of AMPLICOR and automated COBAS AMPLICOR CT/NG tests for Neisseria gonorrhoeae.

Authors:  D H Martin; C Cammarata; B Van Der Pol; R B Jones; T C Quinn; C A Gaydos; K Crotchfelt; J Schachter; J Moncada; D Jungkind; B Turner; C Peyton
Journal:  J Clin Microbiol       Date:  2000-10       Impact factor: 5.948

6.  Growth inhibition of Candida albicans by human vaginal epithelial cells.

Authors:  M M Barousse; C Steele; K Dunlap; T Espinosa; D Boikov; J D Sobel; P L Fidel
Journal:  J Infect Dis       Date:  2001-12-01       Impact factor: 5.226

7.  Prevalence of vulvovaginal candidiasis and susceptibility to fluconazole in women.

Authors:  Tiene G m Bauters; Marc A Dhont; Marleen I L Temmerman; Hans J Nelis
Journal:  Am J Obstet Gynecol       Date:  2002-09       Impact factor: 8.661

Review 8.  Epidemiology and pathogenesis of recurrent vulvovaginal candidiasis.

Authors:  J D Sobel
Journal:  Am J Obstet Gynecol       Date:  1985-08-01       Impact factor: 8.661

9.  Candida-specific antibodies during experimental vaginal candidiasis in mice.

Authors:  Karen L Wozniak; Floyd L Wormley; Paul L Fidel
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

10.  Immune responses to Candida albicans in genetically distinct mice.

Authors:  R F Hector; J E Domer; E W Carrow
Journal:  Infect Immun       Date:  1982-12       Impact factor: 3.441

View more
  28 in total

1.  Diverse nitrogen sources in seminal fluid act in synergy to induce filamentous growth of Candida albicans.

Authors:  Francisco J Alvarez; Kicki Ryman; Cornelis Hooijmaijers; Vincent Bulone; Per O Ljungdahl
Journal:  Appl Environ Microbiol       Date:  2015-02-06       Impact factor: 4.792

Review 2.  Anticandidal immunity and vaginitis: novel opportunities for immune intervention.

Authors:  Antonio Cassone; Flavia De Bernardis; Giorgio Santoni
Journal:  Infect Immun       Date:  2007-06-11       Impact factor: 3.441

3.  Gender differences in risk taking behaviors for Chlamydia trachomatis.

Authors:  Loucine Huckabay; Dennis G Fisher; Grace L Reynolds; Debby Rannalli; Erlyana Erlyana
Journal:  Health Care Women Int       Date:  2020-07-23

Review 4.  Cytokines in the host response to Candida vaginitis: Identifying a role for non-classical immune mediators, S100 alarmins.

Authors:  Junko Yano; Mairi C Noverr; Paul L Fidel
Journal:  Cytokine       Date:  2011-12-17       Impact factor: 3.861

5.  Oral and vaginal epithelial cell anti-Candida activity is acid labile and does not require live epithelial cells.

Authors:  J Yano; E A Lilly; C Steele; D Fortenberry; P L Fidel
Journal:  Oral Microbiol Immunol       Date:  2005-08

6.  Epithelial cell-derived S100 calcium-binding proteins as key mediators in the hallmark acute neutrophil response during Candida vaginitis.

Authors:  Junko Yano; Elizabeth Lilly; Melissa Barousse; Paul L Fidel
Journal:  Infect Immun       Date:  2010-09-07       Impact factor: 3.441

7.  Vaginal epithelial cell anti-Candida albicans activity is associated with protection against symptomatic vaginal candidiasis.

Authors:  Melissa M Barousse; Terri Espinosa; Kathleen Dunlap; Paul L Fidel
Journal:  Infect Immun       Date:  2005-11       Impact factor: 3.441

8.  An intravaginal live Candida challenge in humans leads to new hypotheses for the immunopathogenesis of vulvovaginal candidiasis.

Authors:  Paul L Fidel; Melissa Barousse; Terri Espinosa; Mercedes Ficarra; Joy Sturtevant; David H Martin; Alison J Quayle; Kathleen Dunlap
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

Review 9.  The vaginal mycobiome: A contemporary perspective on fungi in women's health and diseases.

Authors:  L Latéy Bradford; Jacques Ravel
Journal:  Virulence       Date:  2016-09-22       Impact factor: 5.882

Review 10.  Polymicrobial interactions involving fungi and their importance for the environment and in human disease.

Authors:  Seham Z Azzam; Ginelle J Cayme; Luis R Martinez
Journal:  Microb Pathog       Date:  2019-12-24       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.